Phase 2 clinical study supports safety and efficacy of MSC-NTFs
Research still needed for many unknowns
NIH grant funds research into variants that raise risk
Initial successes relieve TMJ and lower extremity pain
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study finds redesigned low-dose decitabine regimen terminates cancer growth, produces durable benefits